AADI Bioscience | Sustainability Performance
Conducts research and development in targeted therapeutics with a focus on oncology and rare diseases. Works on investigational treatments supported by clinical trials. Collaborates with partners and medical institutions to advance drug candidates through regulatory and commercialization pathways.
2011
United States
11 - 50 employees
Biotechnology
$1M - 10M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#6278
Overall#1395
in United States#121
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
P/E ratio
Revenue & EBITDA
$25.0MFY2024 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
R&D intensity
204.0%FY2024
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
-121.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
▲ 4.5%
0.0
▼ 2.5%
0.0
▼ 5.4%
0.0
2031Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
58%
Independent Directors
7 out of 12 incl. management
Overall score
34
Environment
39
Social
15
Governance
49
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
